论文部分内容阅读
目的:探讨采用钳刮术终止妊娠前使用米非司酮配合米索前列醇的临床疗效。方法:选取我站2010年5月～2012年3月收治的90例妊娠10～14周且需要终止妊娠的患者进行回顾性分析。把收治的患者分为对照组与观察组,对照组在钳刮术前给予米索前列醇单独使用,观察组在此基础上配合米非司酮使用。观察两组患者的宫颈扩张、疼痛程度、手术时间以及出血量情况。结果:观察组明显优于对照组,观察组宫颈扩张有效率高达97.8%,而且疼痛度低,出血量少。结论:对于妊娠10～14周孕妇在实行钳刮术前使用米非司酮与米索前列醇,不仅可提高手术成功率,而且减轻患者痛苦、安全性高,并发症少,在临床上有推广应用价值。
Objective: To investigate the clinical efficacy of mifepristone and misoprostol before the termination of pregnancy by forceps curettage. Methods: A retrospective analysis of 90 patients who were treated in our hospital from May 2010 to March 2012 with 10-14 weeks’ gestation and needed termination of pregnancy was retrospectively analyzed. The patients were divided into control group and observation group. The control group was given misoprostol alone before forceps curettage. On the basis of this, the observation group was used with mifepristone. Two groups of patients were observed cervical dilatation, pain level, operation time and bleeding. Results: The observation group was significantly better than the control group, the observation group, the effective rate of cervical dilatation as high as 97.8%, and low pain, less bleeding. Conclusion: The use of mifepristone and misoprostol for pregnant women 10 ~ 14 weeks after pregnancy can not only improve the success rate of operation, but also reduce the pain, safety and less complications of pregnant women Promote the value of application.